系统和局部治疗方法的复发性口腔口炎:一个系统的审查
Karolis Skučas1, Aušra Balčiūnaitė, Nomeda Basevičienė
1Faculty of Odontology, Medical Academy, Lithuanian University of Health Sciences, Taikos pr. 65-23, 50436 Kaunas, Lithuania. karolissk@gmail.com.
Stomatologija
|July 12, 2023
概括
针对复发性口腔炎 (RAS) 的局部治疗方法可以加快愈合速度,缓解疼痛,但不能预防复发. 对于持续的RAS病例,建议使用全身药物.
科学领域:
- 口腔医学是指口腔医学.
- 皮肤病学 皮肤病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 复发性口腔口炎 (RAS) 显著影响患者的生活质量.
- 对RAS的有效管理策略正在不断发展.
结论:
- 对RAS的局部治疗主要是管理疼痛和愈合时间等症状.
- 目前的证据表明,局部药物并不能显著降低RAS复发频率.
- 应考虑使用全身药物来管理RAS的持续或严重病例.
相关概念视频
Peptic Ulcer Disease IV: Management
113
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
113
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
562
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
562
Acute Pharyngitis
922
Introduction
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
922
Tonsillitis II: Management
139
This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
139
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
461
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
461
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
505
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
505


